These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 6270192
1. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro. Ishibashi M, Yamaji T. J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192 [Abstract] [Full Text] [Related]
2. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture. Yamaji T, Ishibashi M, Teramoto A, Fukushima T. Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725 [Abstract] [Full Text] [Related]
6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M, Yamaji T. J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [Abstract] [Full Text] [Related]
7. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease. Elias AN, Gwinup G, Valenta LJ. Clin Endocrinol (Oxf); 1981 Aug; 15(2):151-4. PubMed ID: 6273025 [Abstract] [Full Text] [Related]
8. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances. Matsukura S, Kakita T, Hirata Y, Yoshimi H, Fukase M. J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256 [Abstract] [Full Text] [Related]
14. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease. Lankford HV, Tucker HS, Blackard WG. N Engl J Med; 1981 Nov 19; 305(21):1244-8. PubMed ID: 6270557 [Abstract] [Full Text] [Related]
15. In vitro secretion of ACTH, beta-endorphin and beta-lipotropin in Cushing's disease and Nelson's syndrome. Lüdecke DK, Westphal M, Schabet M, Höllt V. Horm Res; 1980 Nov 19; 13(4-5):259-79. PubMed ID: 6268513 [Abstract] [Full Text] [Related]
17. Inhibitory effect of prepro-thyrotrophin-releasing hormone (178-199) on adrenocorticotrophic hormone secretion by human corticotroph tumours. Pecori Giraldi F, Pesce S, Maroni P, Pagliardini L, Lasio G, Losa M, Cavagnini F. J Neuroendocrinol; 2010 Apr 19; 22(4):294-300. PubMed ID: 20136686 [Abstract] [Full Text] [Related]
18. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. Ishibashi M, Yamaji T. J Clin Endocrinol Metab; 1985 May 19; 60(5):985-93. PubMed ID: 2858494 [Abstract] [Full Text] [Related]
19. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants. McFarlane D, Beech J, Cribb A. Domest Anim Endocrinol; 2006 May 19; 30(4):276-88. PubMed ID: 16115743 [Abstract] [Full Text] [Related]
20. Glucocorticoid incubation of human ACTH-producing pituitary tumours in vitro. A study on ACTH secretion and cell morphology. Thorén M, Anniko M. Arch Otorhinolaryngol; 1986 May 19; 243(2):96-101. PubMed ID: 3013143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]